UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 161

Sortiert nach

Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?

Disease markers, 2018-01, Vol.2018, p.5823870-5

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?

World journal of urology, 2019-04, Vol.37 (4), p.691-699

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of real-time elastography and multiparametric MRI for prostate cancer detection: a whole-mount step-section analysis

American journal of roentgenology (1976), 2014-03, Vol.202 (3), p.W263

2014

Link zum Volltext

Verfügbarkeit prüfen

Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program

PloS one, 2015-07, Vol.10 (7), p.e0134134-e0134134

2015

Link zum Volltext

Verfügbarkeit prüfen

High risk of under-grading and -staging in prostate cancer patients eligible for active surveillance

PloS one, 2015-02, Vol.10 (2), p.e0115537-e0115537

2015

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor

Endocrine-related cancer, 2009-03, Vol.16 (1), p.155-169

2009

Link zum Volltext

Verfügbarkeit prüfen

Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up

European journal of nuclear medicine and molecular imaging, 2020-03, Vol.47 (3), p.740-740

2020

Link zum Volltext

Verfügbarkeit prüfen

The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up

European journal of nuclear medicine and molecular imaging, 2020-03, Vol.47 (3), p.695-712

2020

Link zum Volltext

Verfügbarkeit prüfen

Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate Cancer

Cancers, 2020-07, Vol.12 (8), p.2092

2020

Link zum Volltext

Verfügbarkeit prüfen

Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality

BJU international, 2008-04, Vol.101 (7), p.809-816

2008

Link zum Volltext

Verfügbarkeit prüfen

The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer

Clinical genitourinary cancer, 2018-02, Vol.16 (1), p.e223-e231

2018

Link zum Volltext

Verfügbarkeit prüfen

BPO/LUTS – Aktuelles zur medikamentösen Therapie

Journal für Urologie und Urogynäkologie, 2019-12, Vol.26 (4), p.114-120

2019

Link zum Volltext

Verfügbarkeit prüfen

Long‐term follow up of renal anastomosing hemangioma mimicking renal angiosarcoma

International journal of urology, 2014-08, Vol.21 (8), p.836-838

2014

Link zum Volltext

Verfügbarkeit prüfen

Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer

Biomedicines, 2021-08, Vol.9 (8), p.1004

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk

Proceedings of the National Academy of Sciences - PNAS, 2012-04, Vol.109 (17), p.6686-6691

2012

Link zum Volltext

Verfügbarkeit prüfen

A real‐world comparison of docetaxel versus abiraterone acetate for metastatic hormone‐sensitive prostate cancer

Cancer medicine (Malden, MA), 2021-09, Vol.10 (18), p.6354-6364

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Metastasized Prostate Cancer Beyond Progression After Upfront Docetaxel—A Real-world Data Assessment

European urology focus, 2021-11, Vol.7 (6), p.1308-1315

2021

Link zum Volltext

Verfügbarkeit prüfen

Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction

BJU international, 2005-11, Vol.96 (7), p.1073-1078

2005

Link zum Volltext

Verfügbarkeit prüfen

The Expression of Transcription Factor Activating Transcription Factor 3 in the Human Prostate and its Regulation by Androgen in Prostate Cancer

The Journal of urology, 2006-04, Vol.175 (4), p.1517-1522

2006

Link zum Volltext

Verfügbarkeit prüfen

Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivo

International journal of molecular sciences, 2013-06, Vol.14 (6), p.11942-11962

2013

Link zum Volltext

Verfügbarkeit prüfen

Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia

The Prostate, 2003-09, Vol.57 (1), p.57-65

2003

Link zum Volltext

Verfügbarkeit prüfen

Potentials and Limitations of Real-Time Elastography for Prostate Cancer Detection: A Whole-Mount Step Section Analysis

TheScientificWorld, 2012-01, Vol.2012, p.193213-6

2012

Link zum Volltext

Verfügbarkeit prüfen

(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?

European journal of nuclear medicine and molecular imaging, 2015-07, Vol.42 (8), p.1284-1294

2015

Link zum Volltext

Verfügbarkeit prüfen

The impact of surgery in oligometastatic prostate cancer

Memo - Magazine of European medical oncology, 2018-12, Vol.11 (4), p.305-308

2018

Link zum Volltext

Verfügbarkeit prüfen

Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment response

World journal of urology, 2023-08, Vol.41 (8), p.2043-2050

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Englisch
(159)
Japanisch
(11)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?

Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?

Comparison of real-time elastography and multiparametric MRI for prostate cancer detection: a whole-mount step-section analysis

Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program

High risk of under-grading and -staging in prostate cancer patients eligible for active surveillance

Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor

Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up

The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up

Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate Cancer

Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality

The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer

BPO/LUTS – Aktuelles zur medikamentösen Therapie

Long‐term follow up of renal anastomosing hemangioma mimicking renal angiosarcoma

Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer

Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk

A real‐world comparison of docetaxel versus abiraterone acetate for metastatic hormone‐sensitive prostate cancer

Treatment of Metastasized Prostate Cancer Beyond Progression After Upfront Docetaxel—A Real-world Data Assessment

Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction

The Expression of Transcription Factor Activating Transcription Factor 3 in the Human Prostate and its Regulation by Androgen in Prostate Cancer

Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivo

Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia

Potentials and Limitations of Real-Time Elastography for Prostate Cancer Detection: A Whole-Mount Step Section Analysis

(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?

The impact of surgery in oligometastatic prostate cancer

Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment response

Suchergebnisse filtern